Antituberculosis agents VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis

Bollettino Chimico Farmaceutico

Volumn 141, Issue 5, 2002, Pages 394-396

  Foroumadi, A ^a   Soltani, F ^a   Moshafi, M H ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ciprofloxacin; Mycobacterium avium; Mycobacterium tuberculosis; Single drug resistant

Indexed keywords

2 (2 FURYL)ETHYLCIPROFLOXACIN DERIVATIVE; ANTIMYCOBACTERIAL AGENT; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; EXPERIMENTAL MODEL; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; ANTITUBERCULAR AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0036752173     PISSN: 00066648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Packham S., Gerontology, 2001, 47, 175.
2. Kawahara S., Tada A., Nagara H., Kakkaku, 1999, 74, 71.
3. Yew W, W., Chau C. H., Eur. Respir. J. 1995, 8, 1184.
4. Anagonou S.Y., Gninafon M., Josse R., Kinde-Gazard D., Tawo L. Foundohou J., Bull. Soc. Pathol. Exot. 1993, 86, 144.
5. Cohn D. L., Bustreo F., Raviglione M.C., Clin. Infec. Dis. 1997, 24, 5121.
6. Kaplan J. A., Krieff D.M., Ann. Pharmacother, 1996, 30, 1020.
7. Foroumadi A., Soltani F., Davood A., Emami S., Boll. Chim. Farm. 2002, 141, 247.
8. Foroumadi A., Soltani F. Mirzaei M., Pharmazie, 2002, Accepted for publication.
9. Foroumadi A., Emami S., Haghighat P., Moshafi M.H., Pharm. Pharmacol. Commun. 1999, 5, 591.
10. Skinner P.S., Furney S.K., Jacobs M.R., Klopman G., Ellner JJ., Orme I.M., Antimicrob. Agents Chemother. 1994, 38, 2557.